Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+)

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 1, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

NAD

Interventions

DIETARY_SUPPLEMENT

Niagen

Nicotinamide-Riboside-Chloride Preparation 1000mg/day

OTHER

Placebo

Placebo Preperation

Trial Locations (1)

Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Berlin

All Listed Sponsors

collaborator

ChromaDex, Inc.

INDUSTRY

lead

Charite University, Berlin, Germany

OTHER

NCT06005350 - Nicotinamide Riboside Impact on Extracellular Nicotinamide Adenine Dinucleotide (NAD+) | Biotech Hunter | Biotech Hunter